Paper Portfolio Tracker

AI Infrastructure + Macro

Total Gain / Loss
$0
+0.0% since inception
Portfolio Value
started at $10,000
Inception
Positions
6
+ 20% cash reserve
Last Updated
weekly digest
Portfolio Value Over Time
Positions · Hover for thesis
Portfolio Assessment & Recommendations
As of Apr 27, 2026
CRWV HOLD WITH CAUTION

Up 22.4% from entry — a strong gain for 18 days. But two red flags emerged this week: CEO Michael Intrator sold $35.8M in shares via a pre-set plan, and the company priced $1B in 9.75% senior notes due 2031. Debt load is rising faster than the backlog narrative warrants. The underlying thesis (Meta/OpenAI GPU cloud monopoly) remains intact, but the May 20 Q1 earnings call is now critical — revenue needs to trend toward the $5B+ 2026 projection to justify the current price. If earnings disappoint or debt guidance worsens, this moves to TRIM territory.

VRT STRONG HOLD

The thesis was validated ahead of schedule. Q1 earnings on April 22 delivered diluted EPS +136% YoY, revenue $2.65B (+30%), and full-year guidance was raised. JPMorgan and Morgan Stanley both raised price targets to $350. At $323, the stock is approaching the $320 target set at inception. Consider setting a trailing stop at $290 to protect gains, while leaving room to run toward analyst targets. This is the cleanest WIN in the portfolio — do not let it become a round-trip.

SHLD UNDER REVIEW

The thesis is under pressure. SHLD has fallen 9.5% since entry despite active geopolitical tensions — the market may be pricing in a peace/de-escalation scenario in Ukraine. Short interest surged 253% in April, which means institutional money is actively betting against this ETF. The NATO summit in June is the last major catalyst. If there is no meaningful spending pledge announcement by then, consider closing this position and redeploying the $1,358 into a position with stronger near-term momentum. Do not average down.

URA STRONG HOLD

Up 15.2% with all tailwinds intact. X-energy surged 27% on AI nuclear IPO interest, and $4.6B flowed into uranium ETFs over the past year. The AI power demand thesis is structural — US EIA projects record power demand in 2026, continuing into 2027. No action needed. Watch for SMR (small modular reactor) permit announcements and Microsoft-style nuclear power deals as potential catalysts for the next leg up toward the $65 target.

GRID HOLD

Quietly up 10% with minimal news — exactly what a "knowledge gap" position should do. The grid bottleneck thesis has not become mainstream yet, which means the entry window may still be open for conviction investors. At current pace it is outperforming the original +35–50% target timeline. No action needed; revisit at the 6-month mark or on any FERC grid policy announcement.

COPX calls ACTION REQUIRED

The underlying is at $82.38 — essentially flat from the $82 entry — while the $90 strike calls are deeply out-of-the-money and bleeding time decay. The estimated loss is already ~$100 and accelerating daily. Two options: (1) Close now and recover whatever premium remains, limiting further time decay loss; (2) Roll to a lower strike or longer expiry if you still believe copper has a near-term catalyst. If no specific catalyst is visible in the next 30 days, close the position. A clean $1,000 loss is better than watching time decay take it to zero.

Strategic Recommendations
Consider Adding
With $2,000 in cash reserve, watch for a post-FOMC dip in CRWV or VRT to add to the highest-conviction positions. A 5–8% pullback on either would be a reasonable add point. Also watch for the Crusoe Energy S-1 filing — that is the designated IPO deploy target for the cash reserve.
Consider Trimming
VRT is approaching its original target. Consider selling 2–3 shares (of 6) if it touches $320, locking in partial gains and reducing risk ahead of any hyperscaler CapEx cut news. SHLD is the weakest thesis — if it does not recover above $72 by the NATO summit, close the full position.
Watch Closely
CRWV Q1 earnings on May 20 is the single most important event in the next 30 days. Revenue vs. $5B+ guidance and any debt/equity update will determine whether the thesis strengthens or breaks. Mark your calendar and review the position one week before to decide whether to hold through earnings or reduce exposure.